Lifestyle factors, medications and colon cancer survival stratified by biomarkers
: A molecular cancer epidemiology approach

  • Yasemin ADALI

Student thesis: Doctoral ThesisDoctor of Philosophy

Abstract

Colorectal cancer (CRC) has a complex multi-mechanistic and multi-factorial aetiology, with different tumours having distinct genomic and epigenomic alterations. Tumours with similar characteristics, on the other hand, can be classified together due to their presumed common development mechanism. Traditionally this classification has been solely on the basis of tumour morphology. Molecular understanding of CRC has improved significantly in recent years, culminating in a proposed consensus molecular classification of CRC, but we still do not fully comprehend the interactions between molecular biomarkers, commonly used medications, and lifestyle factors on survival outcomes.

For these reasons, the overall aim of this thesis was to examine how specific molecular and immune biomarkers, and exposures (including commonly used medications, lifestyle factors) interact to influence survival of colon cancer patients within a large population-based cohort.In summary, subgroups of patients who are tobacco smokers appear to have poorer prognosis according to their molecular characteristics; the evidence is less consistent for alcohol use. Preliminary evidence for deleterious association between ARB use and patients with MSS status tumours requires further investigate to optimise patient safety and outcomes. A large resource has been created to enable future transcriptional biomarker studies that would also address a major gap in molecular pathology epidemiology (MPE) cancer studies. Such clarification of molecular and immune specific associations between lifestyle factors, medications and CRC survival would help to inform analysis strategies for ongoing trials in this subject and would also guide the design of targeted stratified trials in the future.

Thesis embargoed until 31 December 2023
Date of AwardDec 2022
Original languageEnglish
Awarding Institution
  • Queen's University Belfast
SponsorsDirectorate General of Higher Foreign Education, the Ministry of National Education in Turkey
SupervisorPhilip Dunne (Supervisor) & Helen Coleman (Supervisor)

Keywords

  • molecular cancer epidemiology
  • lifestyle factors
  • medications
  • colon cancer
  • alcohol
  • smoking
  • biomarkers
  • immune biomarkers
  • molecular biomarkers

Cite this

'